Additional Project 2 Research Activities Sample Clauses

Additional Project 2 Research Activities. (a) At GSK’s sole discretion, GSK may initiate additional collaborative research activities under Project 2 to be conducted by the Parties in accordance with this Schedule 2, which may include activities directed to (i) the research and development of the compound referred to as [ * ] or (ii) other existing Collaboration Compounds or new compounds targeting the Project 2 Target (i.e., LeuRS), under one or more TPP Subprograms (such activities, collectively, the “New Project 2 Research Program”). The Research Collaboration Term set out in Section 2.3 of the Agreement shall be extended for [ * ] from the date on which any such New Project 2 Research Program is initiated by GSK, provided such initiation takes place before [ * ], and subject to any further extension agreed between the Parties. If once the New Project 2 Research Program has been initiated, GSK wishes to extend the Research Collaboration Term further (beyond the extension prescribed above) then in the event that Anacor does not agree to any such further extension, Anacor shall grant to GSK the necessary right and license under Anacor IP to continue the New Project 2 Research Program itself or through its nominated Third Party contractors in accordance with Section 5(b) below, it being understood that any such Third Party contractors will be selected by GSK according to GSK’s standard procedures, and will be subject to appropriate terms of engagement including with respect to confidentiality and protection of IP (including without limitation any Anacor IP). Any such continuation by GSK will be deemed to be a continuation of the Research Collaboration Term. GSK shall have the [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. right to terminate the New Project 2 Research Program, or any Project 2 TPP Subprogram or compound within it, at any time. The consequences of any such termination shall be as set forth in Sections 8 and 9 below. If the Research Collaboration Term has been extended, but GSK has terminated the New Project 2 Research Program during such extension, then the Research Collaboration Term shall be deemed to expire as of the effective date of termination of the New Project 2 Research Program.
Sample 1
AutoNDA by SimpleDocs

Related to Additional Project 2 Research Activities

  • Development Activities NovaDel shall not be required to commence any Development Activities until Licensee has paid at least twenty-five percent (25%) of the non-refundable License Fee described in Section 4.4.

  • Development Plan As defined in Section 3.2(a).

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Development Program A. Development Activities to be Undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Schedule The schedule for design and development of the "BASE BUILDING WORK" (as defined below) and the "TENANT IMPROVEMENTS" (as defined below), including, without limitation, the time periods for preparation, delivery, review, and approval of construction documents and performance pursuant to such documents, shall be in accordance with the Development Schedule attached hereto as Schedule A, subject to adjustment as mutually agreed by the parties in writing or as provided in this Work Letter (the "DEVELOPMENT SCHEDULE").

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • Project Plan Based on the Project Specifications, Omnicare CR has provided a description of services to be performed for Sponsor’s “A multi-center, randomized, double-blind, double-dummy, vehicle-controlled sequential cohort study to determine the safety of PEP005 0.025% and 0.05% topical gel in patients with actinic keratoses” (hereinafter “the Project”) and associated costs. Changes made in the Project scope, at any time during the Project, will result in a corresponding adjustment to the Project costs.

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

  • Development of the Project The Board of Managers shall take such actions as shall be required to cause either the Company or the Management Company (as defined in Section 9(b) below) to perform and complete the construction and other development work as contemplated and/or required under the NVR Purchase and Sale Agreements, or any other construction company selected by the Board of Managers (the “Development Work”), substantially in accordance with the Project Plan, at a cost to the Company not exceeding the total cost set forth in the Budget, in a manner consistent with this Agreement and all applicable laws, ordinances, rules, regulations or requirements (including, without limitation, those with respect to discrimination) of governmental authorities, and in compliance with any covenants, conditions or restrictions affecting all or any portion of the Property.

Time is Money Join Law Insider Premium to draft better contracts faster.